We are live on ! Find out more
PODD icon

Insulet

525 hedge funds and large institutions have $20.6B invested in Insulet in 2022 Q4 according to their latest regulatory filings, with 103 funds opening new positions, 158 increasing their positions, 197 reducing their positions, and 39 closing their positions.

New
Increased
Maintained
Reduced
Closed

164% more first-time investments, than exits

New positions opened: 103 | Existing positions closed: 39

50% more funds holding in top 10

Funds holding in top 10: 69 (+3)

27% more capital invested

Capital invested by funds: $16.3B → $20.6B (+$4.35B)

12% more funds holding

Funds holding: 468525 (+57)

1.31% less ownership

Funds ownership: 102.27%100.97% (-1.3%)

20% less repeat investments, than reductions

Existing positions increased: 158 | Existing positions reduced: 197

41% less call options, than puts

Call options by funds: $57.1M | Put options by funds: $96.5M

Holders
525
Holders Change
+57
Holders Change %
+12.18%
% of All Funds
8.42%
Holding in Top 10
9
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+50%
% of All Funds
0.14%
New
103
Increased
158
Reduced
197
Closed
39
Calls
$57.1M
Puts
$96.5M
Net Calls
-$39.4M
Net Calls Change
-$14.9M

PODD Hedge Fund Activity: Q4 2022 in Review

525 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in Insulet (PODD) for Q4 2022, worth a combined $20.6B — up 27% from $16.3B a quarter earlier.

Buyers outnumbered sellers: 103 funds opened new PODD positions and 39 closed out — a net gain of 64 holders — while 158 added to existing stakes and 197 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $154M. The largest seller was Primecap Management, cutting an estimated $98.2M.

  • 525 institutional investors held Insulet (PODD) as of Q4 2022, up from 468 in Q3 2022.
  • Funds reported $20.6B of Insulet stock for Q4 2022, up 27% quarter-over-quarter.
  • 103 funds opened new Insulet positions in Q4 2022 and 39 closed out, a net change of +64 holders.
  • The largest Insulet buyer in Q4 2022 was Wellington Management Group, an estimated $154M added.
  • The largest Insulet seller in Q4 2022 was Primecap Management, an estimated $98.2M sold.

Based on aggregated 13F filings for Q4 2022.